MX2010009157A - Suministro mejorado de un agente terapeutico para tejidos oculares a traves de iontoforesis. - Google Patents
Suministro mejorado de un agente terapeutico para tejidos oculares a traves de iontoforesis.Info
- Publication number
- MX2010009157A MX2010009157A MX2010009157A MX2010009157A MX2010009157A MX 2010009157 A MX2010009157 A MX 2010009157A MX 2010009157 A MX2010009157 A MX 2010009157A MX 2010009157 A MX2010009157 A MX 2010009157A MX 2010009157 A MX2010009157 A MX 2010009157A
- Authority
- MX
- Mexico
- Prior art keywords
- iontophoresis
- therapeutic
- enhanced delivery
- ocular tissues
- delivery
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F9/00—Methods or devices for treatment of the eyes; Devices for putting-in contact lenses; Devices to correct squinting; Apparatus to guide the blind; Protective devices for the eyes, carried on the body or in the hand
- A61F9/0008—Introducing ophthalmic products into the ocular cavity or retaining products therein
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
- A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
- A61K9/0009—Galenical forms characterised by the drug release technique; Application systems commanded by energy involving or responsive to electricity, magnetism or acoustic waves; Galenical aspects of sonophoresis, iontophoresis, electroporation or electroosmosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/02—Details
- A61N1/04—Electrodes
- A61N1/0404—Electrodes for external use
- A61N1/0408—Use-related aspects
- A61N1/0428—Specially adapted for iontophoresis, e.g. AC, DC or including drug reservoirs
- A61N1/0448—Drug reservoir
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/20—Applying electric currents by contact electrodes continuous direct currents
- A61N1/30—Apparatus for iontophoresis, i.e. transfer of media in ionic state by an electromotoric force into the body, or cataphoresis
- A61N1/303—Constructional details
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/02—Details
- A61N1/04—Electrodes
- A61N1/0404—Electrodes for external use
- A61N1/0408—Use-related aspects
- A61N1/0428—Specially adapted for iontophoresis, e.g. AC, DC or including drug reservoirs
- A61N1/0432—Anode and cathode
- A61N1/044—Shape of the electrode
Abstract
Se describen en la presente formulaciones de dexametasona o uno de sus profármacos adecuados para suministro a través de iontoforesis ocular y sus métodos de uso.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US3126708P | 2008-02-25 | 2008-02-25 | |
US4795008P | 2008-04-25 | 2008-04-25 | |
PCT/US2009/034977 WO2009108626A2 (en) | 2008-02-25 | 2009-02-24 | Enhanced delivery of a therapeutic to ocular tissues through iontophoresis |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2010009157A true MX2010009157A (es) | 2010-09-24 |
Family
ID=41016683
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2010009157A MX2010009157A (es) | 2008-02-25 | 2009-02-24 | Suministro mejorado de un agente terapeutico para tejidos oculares a traves de iontoforesis. |
Country Status (10)
Country | Link |
---|---|
US (4) | US20090306579A1 (es) |
EP (1) | EP2249921B1 (es) |
JP (1) | JP2011512903A (es) |
CN (1) | CN101970042A (es) |
AU (1) | AU2009219426B2 (es) |
BR (1) | BRPI0908229A8 (es) |
CA (1) | CA2716390C (es) |
IL (1) | IL207014A0 (es) |
MX (1) | MX2010009157A (es) |
WO (1) | WO2009108626A2 (es) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101970042A (zh) | 2008-02-25 | 2011-02-09 | 眼门药品公司 | 经由离子电渗法增强递送治疗药物至眼部组织 |
EP2370155B1 (en) * | 2008-12-31 | 2018-07-04 | Eyegate Pharmaceuticals, Inc. | System for ocular iontophoresis with buffering |
US20130310732A1 (en) * | 2011-01-12 | 2013-11-21 | Sooft Italia Spa | Corneal delivery of cross-linking agents by iontophoresis for the treatment of keratoconus and related ophthalmic compositions |
WO2012162459A1 (en) * | 2011-05-26 | 2012-11-29 | Pepose Jay | Device and method for administering eye medications |
JP5463511B1 (ja) * | 2013-05-13 | 2014-04-09 | 株式会社メディカル・アート | イオン泳動式皮膚感染症治療装置 |
WO2015197097A1 (en) | 2014-06-26 | 2015-12-30 | Xigen Inflammation Ltd. | New use for jnk inhibitor molecules for treatment of various diseases |
WO2014206427A1 (en) | 2013-06-26 | 2014-12-31 | Xigen Inflammation Ltd. | New use of cell-permeable peptide inhibitors of the jnk signal transduction pathway for the treatment of various diseases |
CN106413642B (zh) * | 2014-04-23 | 2019-03-08 | 塞罗斯医学有限责任公司 | 真空辅助药物递送装置 |
CN106794152A (zh) * | 2014-08-13 | 2017-05-31 | 约翰霍普金斯大学 | 用于预防角膜同种异体移植物排斥和新生血管形成的载有糖皮质激素的纳米颗粒 |
WO2016100972A2 (en) * | 2014-12-19 | 2016-06-23 | Kemin Industries, Inc. | Intraocular delivery of bioactive molecules using iontophoresis |
WO2016118933A1 (en) | 2015-01-22 | 2016-07-28 | Eyegate Pharmaceuticals, Inc. | Iontophoretic contact lens |
KR102450674B1 (ko) | 2015-03-05 | 2022-10-04 | 오클랜드 유니서비시즈 리미티드 | 안과용 조성물 및 이의 사용 방법 |
WO2019089537A1 (en) | 2017-10-31 | 2019-05-09 | Tusker Medical, Inc. | Systems, apparatus, and methods for delivery of therapeutic substance to nasal cavity |
CN113660934A (zh) | 2018-11-21 | 2021-11-16 | 特默罗制药股份有限公司 | 罗非昔布的纯化形式、制备方法和用途 |
US11161833B1 (en) | 2021-04-09 | 2021-11-02 | Tremeau Pharmaceuticals, Inc. | Deuterated etoricoxib, methods of manufacture, and use thereof |
Family Cites Families (39)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4221787A (en) * | 1978-03-28 | 1980-09-09 | Interx Research Corporation | Esteramide prodrugs of anti-inflammatory corticosteroids |
US4279900A (en) * | 1978-07-13 | 1981-07-21 | Intrex Research Corporation | Prodrugs for the improved delivery of halogen-containing glucocorticosteroids |
US4456602A (en) * | 1982-08-23 | 1984-06-26 | The Upjohn Company | Amine containing ester prodrugs of corticosteroids |
US4443440A (en) * | 1982-08-30 | 1984-04-17 | The Upjohn Company | Amine containing ester prodrugs of corticosteroids |
US4472392A (en) * | 1983-01-21 | 1984-09-18 | The Upjohn Company | Sulfonate containing ester prodrugs of corticosteroids |
US4469689A (en) * | 1983-03-30 | 1984-09-04 | The Upjohn Company | Sulfonate containing ester prodrugs of corticosteroids |
US4588718A (en) * | 1984-03-28 | 1986-05-13 | The Upjohn Company | Carboxy containing ester prodrugs of corticosteroids |
GB9024005D0 (en) * | 1990-11-05 | 1990-12-19 | British Bio Technology | Process for amplifying nucleic acid |
US5222936A (en) * | 1991-09-25 | 1993-06-29 | Stephen Robert L | Intracorporeal iontophoretic method |
DE4236237A1 (de) * | 1992-10-27 | 1994-04-28 | Behringwerke Ag | Prodrugs, ihre Herstellung und Verwendung als Arzneimittel |
EP0647450A1 (en) * | 1993-09-09 | 1995-04-12 | BEHRINGWERKE Aktiengesellschaft | Improved prodrugs for enzyme mediated activation |
ATE195127T1 (de) * | 1993-09-29 | 2000-08-15 | Nissin Food Products Ltd | In stellung 21 substituierte steroide |
US6650934B2 (en) * | 1996-12-17 | 2003-11-18 | Alza Corp | Polymeric foam reservoirs for an electrotransport delivery device |
US6050934A (en) * | 1997-02-26 | 2000-04-18 | Cv Dynamics, Inc. | Urinary catheter having palpitatable discharge valve with protective shoulders |
US6090800A (en) * | 1997-05-06 | 2000-07-18 | Imarx Pharmaceutical Corp. | Lipid soluble steroid prodrugs |
CN1063944C (zh) * | 1997-04-14 | 2001-04-04 | 齐鲁制药厂 | 眼用复方妥布霉素混悬液的制法 |
FR2773320B1 (fr) * | 1998-01-05 | 2000-03-03 | Optisinvest | Dispositif pour le transfert intraoculaire de produits actifs par iontophorese |
JP2000316991A (ja) * | 1999-05-13 | 2000-11-21 | Hisamitsu Pharmaceut Co Inc | イオントフォレーシス装置の電極構造体及びその製造方法 |
JP4414517B2 (ja) | 1999-09-01 | 2010-02-10 | 久光製薬株式会社 | イオントフォレーシス用デバイス構造体 |
AU776609B2 (en) | 1999-09-24 | 2004-09-16 | Novartis Ag | Topical suspension formulations containing ciprofloxacin and dexamethasone |
US6395756B2 (en) * | 1999-12-23 | 2002-05-28 | Novartis Ag | Use of ophthalmic agent |
US6697668B2 (en) | 2001-01-25 | 2004-02-24 | Iomed, Inc. | Ocular iontophoretic device and method for using the same |
US20030023228A1 (en) * | 2001-07-20 | 2003-01-30 | Parkinson Thomas M. | Ocular iontophoretic device and method for using the same |
EP1596823A2 (en) | 2003-02-21 | 2005-11-23 | Sun Pharmaceuticals Industries Ltd. | A stable ophthalmic composition |
JP3493359B1 (ja) * | 2003-03-20 | 2004-02-03 | 宣美 辛島 | イオン泳動式治療装置 |
FR2855761B1 (fr) * | 2003-06-03 | 2006-02-24 | Optis France Sa | Dispositif oculaire de delivrance variable de principes actifs par iontophorese |
JP4820647B2 (ja) * | 2003-08-29 | 2011-11-24 | 久光製薬株式会社 | イオントフォレーシス投与組成物 |
CA2562356A1 (en) * | 2004-04-08 | 2005-10-27 | Retmed Pty Ltd | Treatment of ophthalmic conditions with mineralcorticoids |
FR2869531B1 (fr) * | 2004-04-30 | 2006-07-14 | Optis France Sa Sa | Dispositif de iontophorese oculaire diminuant les irritations |
US20060110428A1 (en) | 2004-07-02 | 2006-05-25 | Eugene Dejuan | Methods and devices for the treatment of ocular conditions |
WO2006072887A1 (en) | 2005-01-05 | 2006-07-13 | Eyegate Pharma Sa | Ocular iontophoresis device for delivering sirna and aptamers |
US8386030B2 (en) * | 2005-08-08 | 2013-02-26 | Tti Ellebeau, Inc. | Iontophoresis device |
US8099162B2 (en) * | 2005-11-29 | 2012-01-17 | Eyegate Pharma, S.A.S. | Ocular iontophoresis device |
US7767217B2 (en) * | 2006-03-14 | 2010-08-03 | Foresight Biotherapeutics | Ophthalmic compositions comprising povidone-iodine |
US8048448B2 (en) * | 2006-06-15 | 2011-11-01 | Abbott Cardiovascular Systems Inc. | Nanoshells for drug delivery |
US20080027371A1 (en) * | 2006-07-26 | 2008-01-31 | Higuchi John W | Method and device for minimally invasive site specific ocular drug delivery |
WO2008057360A1 (en) * | 2006-11-02 | 2008-05-15 | Riolan Technologies, Inc. | Methods of treating an ocular allergy with low dose dexamethasone |
CN101970042A (zh) | 2008-02-25 | 2011-02-09 | 眼门药品公司 | 经由离子电渗法增强递送治疗药物至眼部组织 |
US8030297B2 (en) * | 2008-05-14 | 2011-10-04 | Otonomy, Inc. | Controlled release corticosteroid compositions and methods for the treatment of OTIC disorders |
-
2009
- 2009-02-24 CN CN2009801063912A patent/CN101970042A/zh active Pending
- 2009-02-24 BR BRPI0908229A patent/BRPI0908229A8/pt not_active Application Discontinuation
- 2009-02-24 US US12/391,836 patent/US20090306579A1/en not_active Abandoned
- 2009-02-24 AU AU2009219426A patent/AU2009219426B2/en not_active Ceased
- 2009-02-24 CA CA2716390A patent/CA2716390C/en not_active Expired - Fee Related
- 2009-02-24 JP JP2010547849A patent/JP2011512903A/ja active Pending
- 2009-02-24 EP EP09714994.2A patent/EP2249921B1/en active Active
- 2009-02-24 WO PCT/US2009/034977 patent/WO2009108626A2/en active Application Filing
- 2009-02-24 MX MX2010009157A patent/MX2010009157A/es active IP Right Grant
-
2010
- 2010-07-15 IL IL207014A patent/IL207014A0/en active IP Right Grant
-
2012
- 2012-05-11 US US13/469,481 patent/US10376463B2/en not_active Expired - Fee Related
-
2013
- 2013-10-22 US US14/060,055 patent/US9149525B2/en not_active Expired - Fee Related
-
2016
- 2016-03-10 US US15/066,689 patent/US9820935B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
US20140046242A1 (en) | 2014-02-13 |
CN101970042A (zh) | 2011-02-09 |
US10376463B2 (en) | 2019-08-13 |
IL207014A0 (en) | 2010-12-30 |
BRPI0908229A2 (pt) | 2017-06-13 |
WO2009108626A2 (en) | 2009-09-03 |
JP2011512903A (ja) | 2011-04-28 |
BRPI0908229A8 (pt) | 2017-10-10 |
WO2009108626A3 (en) | 2010-01-07 |
US20160263024A1 (en) | 2016-09-15 |
CA2716390C (en) | 2016-08-23 |
US9820935B2 (en) | 2017-11-21 |
US20120283231A1 (en) | 2012-11-08 |
US9149525B2 (en) | 2015-10-06 |
EP2249921B1 (en) | 2020-06-17 |
EP2249921A4 (en) | 2015-02-11 |
EP2249921A2 (en) | 2010-11-17 |
AU2009219426A1 (en) | 2009-09-03 |
US20090306579A1 (en) | 2009-12-10 |
CA2716390A1 (en) | 2009-09-03 |
AU2009219426B2 (en) | 2015-12-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2010009157A (es) | Suministro mejorado de un agente terapeutico para tejidos oculares a traves de iontoforesis. | |
WO2009023311A9 (en) | Transcutaneous delivery of therapeutic agents | |
CA2711696C (en) | Therapeutic compositions for treatment of ocular inflammatory disorders | |
SG10201510586PA (en) | Treatment of Eye Diseases And Excessive Neovascularization Using A Combined Therapy | |
MX370543B (es) | Profarmacos neutralizantes del factor de crecimiento endotelial vascular para el tratamiento de afecciones oculares. | |
EP2493475A4 (en) | COSMETIC METHODS AND PREPARATIONS FOR THE PROLONGED RELEASE OF THERAPEUTIC AGENTS IN THE EYE | |
ZA201400616B (en) | Methods and devices for drug delivery to ocular tissue using microneedle | |
EP2187743A4 (en) | FORMULATIONS FOR THE TREATMENT OF DISEASES OR EYE DISORDERS | |
MX369616B (es) | Composiciones cutaneas y metodos para su uso. | |
MX357801B (es) | Agentes dirigidos a gadd45beta. | |
HK1163500A1 (en) | Pharmaceutical composition for the treatment of heart diseases | |
MY161593A (en) | Oral formulations of cytidine analogs and methods of use thereof | |
MY173215A (en) | Acetylcysteine compositions and methods of use thereof | |
MX2010002736A (es) | Derivados de 1-amino-alquilciclohexano para el tratamiento de tinnitus coclear. | |
ZA201200017B (en) | Formulations for the treatment of deeep tissue pain | |
WO2009114703A3 (en) | Combination therapy for the treatment of cancer | |
EA201190337A1 (ru) | Способ лечения | |
AU324215S (en) | Handpiece for massage or therapy | |
EP2306824A4 (en) | IONTOPHORETIC DELIVERY OF CURCUMINE AND CURCUMINANALOGUE FOR THE TREATMENT OF MORBUS ALZHEIMER | |
WO2012040636A3 (en) | Compounds and methods for treating diseases mediated by protease activated receptors | |
WO2011044523A3 (en) | Compositions and methods for treating obesity | |
WO2009132234A3 (en) | Medical devices, polymers, compositions, and methods for delivering a haloacetate | |
IL198202A0 (en) | Peptide-cytotoxic conjugates | |
MX2010006019A (es) | Metodos para administrar acido ribonucleico pequeño de interferencia (arnsi) mediante iontoforesis. | |
UA112981C2 (uk) | Варіант людського gdnf |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
GB | Transfer or rights |
Owner name: EYEGATE PHARMACEUTICALS, INC. |
|
FG | Grant or registration |